Catalyst Wire Dossier Catalyst Wire Dossier

prologolimab

prologolimab
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for prologolimab, covering 2023-12-19 to 2026-04-27. Get the full timeline:

Most recent: Clinical Trial Update: Neoadjuvant Prolgolimab Monotherapy in Locally Advanced MMR-deficient Colorectal Cancer [Phase 2]

See pricing